M. Bilal Abid, Medical Director, Blood and Marrow Transplantation and Cellular Therapy Program at Texas Tech University Health Sciences Center, shared a post on LinkedIn by Matt Sherer, Director of Oncology Service Line at UMC Health System, adding:
“Thrilled to join Texas Tech University Health Sciences Center and UMC Health System Cancer Center, where a team of academic clinicians and scientists is furthering cancer care and research to serve West Texas.
Under Thomas Hutson’s visionary leadership, disease-specific teams are bringing cutting-edge clinical trials and novel cancer therapies closer to home for people in this half of the state. Our trial (I-III) start-up times – CDA execution, SIV, to randomization – are short, and a highly skilled research team of PhDs and CRCs ensures patient safety and regulatory requirements. This is in addition to large-scale basic research cancer research happening at Texas Tech University.
My role is to build the first comprehensive malignant hematology, cellular therapy, and transplant program in the region where patients receive curative (just about now!) CAR T-cell therapy, bispecific antibodies, and transplantation without having to travel hundreds of miles. I am truly humbled and appreciate the trust people in West Texas have put in me and will do my best to live up to the expectation.
I am thankful to my career mentors for taking their time over the years to invest in my training! Parameswaran Hari, Dario Compana, Wafik S. El-Deiry, Irfan Vaziri, and many others along the way!
We invite regional community partners to refer complex patients, and industrial/pharmaceutical friends to bring clinical trials to the region. Remember to buy a ticket to enjoy a wholesome game experience of D1 sports and athletics during your visit to Lubbock. Together, we are destined for bigger and better for the Western half of Texas!”
Quoting Matt Sherer’s post:
“M. Bilal Abid is another superstar physician who recently joined our Hem/Onc team at UMC Health System and Texas Tech University Health Sciences Center. We are excited and look forward to what he will accomplish in helping us build our academic cancer program to serve West Texas and Eastern New Mexico.”
More posts featuring M. Bilal Abid on OncoDaily.